第1页å‚è§é™„ä»¶(1053KB,2页)。
[摘è¦] 目的:比较甲磺酸罗哌å¡å› 与ç›é…¸ç½—哌å¡å› 用于腋路臂丛神ç»é˜»æ»žçš„æœ‰æ•ˆæ€§å’Œå®‰å…¨æ€§ã€‚方法:48例ASAâ… ï½žâ…¡çº§æ‹©æœŸä¸Šè‚¢æ‰‹æœ¯æ‚£è€…éšæœºåˆ†ä¸º0.5%ç›é…¸ç½—哌å¡å› 组(A组)å’Œ0.596%甲磺酸罗哌å¡å› 组(B组)。æ¯ç»„24例,两组患者å‡è¡Œè…‹è·¯è‡‚丛神ç»é˜»æ»žï¼Œè§‚察感觉与è¿åŠ¨ç¥žç»é˜»æ»žèµ·æ•ˆæ—¶é—´ã€æŒç»æ—¶é—´åŠä¸è‰¯å应,评价麻醉效果。结果:在感觉与è¿åŠ¨ç¥žç»é˜»æ»žçš„èµ·æ•ˆæ—¶é—´ã€æŒç»æ—¶é—´åŠä¸è‰¯å应方é¢ï¼Œ0.596%甲磺酸罗哌å¡å› 与0.5%ç›é…¸ç½—哌å¡å› æœªè§æ˜Žæ˜¾å·®å¼‚。结论:0.596%甲磺酸罗哌å¡å› 与0.5%ç›é…¸ç½—哌å¡å› 应用于腋路臂丛神ç»é˜»æ»žï¼Œå…·æœ‰ç›¸ä¼¼çš„æœ‰æ•ˆæ€§å’Œå®‰å…¨æ€§ã€‚
[关键è¯] 甲磺酸罗哌å¡å› ï¼›ç›é…¸ç½—哌å¡å› ;腋路臂丛神ç»é˜»æ»ž
[ä¸å›¾åˆ†ç±»å·] R971.2 [æ–‡çŒ®æ ‡è¯†ç ]B[æ–‡ç« ç¼–å·]1673-7211(2009)01(a)-067-02
Comparative study of Ropivacaine Mesylate and Ropivacaine Hydrochloride for axillary brachial plexus block
WANG Wei-hua, ZHANG Qing, HOU Xi-long
(Department of Anesthesiology, Dalian Second People's Hospital, Dalian116011, China)
[Abstract] Objective: To compare the efficacy and safety of Ropivacaine Mesylate and Ropivacaine Hydrochloride for axillary brachial plexus block. Methods: 48 ASAâ… orâ…¡patients scheduled for upper extremity surgery were randomly divided into two groups: 0.5% Ropivacaine Hydrochloride group (group A) and 0.596% Ropivacaine Mesylate group (group B), with 24 patients in each group. All patients were performed with axillary brachial plexus block. Then the initiating time, lasting time of sensory and motor block as well as the adverse reaction were observed, and the anesthetic effect was evaluated. Results: No significant difference of the initiating or lasting time, or even the adverse reaction of sensory and motor block was observed between the two groups. Conclusion: 0.5% Ropivacaine Hydrochloride and 0.596% Ropivacaine Mesylatehave similar efficacy and safety in the application of axillary brachial plexus block.
[Key words] Ropivacaine Mesylate; Ropivacaine Hydrochloride; Axillary brachial plexus block
ç›é…¸ç½—哌å¡å› 是一ç§é•¿æ•ˆé…°èƒºç±»å±€éƒ¨éº»é†‰è¯ã€‚与布比å¡å› ç›¸æ¯”ï¼Œå…¶ä¸æž¢ç¥žç»ç³»ç»Ÿå’Œå¿ƒè„毒性较å°[1,2],是一ç§è¾ƒä¸ºç†æƒ³çš„局麻è¯ã€‚甲磺酸罗哌å¡å› 是将ç›é…¸ç½—哌å¡å› çš„ç›é…¸æ ¹æ”¹ä¸ºç”²ç£ºé…¸æ ¹åŽçš„一ç§å›½äº§æ–°åž‹é…°èƒºç±»å±€éº»è¯[3]。有资料[4]显示,0.894%甲磺酸罗哌å¡å› ä¸Žç‰æ•ˆæµ“度的0.75%ç›é…¸ç½—哌å¡å› 用于腰段硬膜外阻滞的效应基本相åŒã€‚æœ¬ç ”ç©¶æ‹Ÿé€šè¿‡éšæœºå¯¹ç…§è¯•验方案比较甲磺酸罗哌å¡å› å’Œç›é…¸ç½—哌å¡å› 用于腋路臂丛神ç»é˜»æ»žçš„临床效果和安全性。
1 资料与方法
1.1 一般资料
择期上肢手术患者48例,ASAâ… ï½žâ…¡çº§ï¼Œå¹´é¾„17~59å²ï¼Œä½“é‡46~92 kg。其ä¸ï¼Œå‰è‡‚外伤22例,手外伤26例。患者心ã€è„‘ã€è‚ºåŠŸèƒ½å‡æ— 异常。
1.2 麻醉方法
éšæœºå°†æ‚£è€…分为两组,A组:0.5%ç›é…¸ç½—哌å¡å› 组(n=24),1%ç›é…¸ç½—哌å¡å› (英国阿斯利康公å¸ï¼Œäº§å“批å·ï¼šIK1607)15 ml+生ç†ç›æ°´15 mlï¼›B组:0.596%甲磺酸罗哌å¡å› 组(n=24),0.894%甲磺酸罗哌å¡å› (æ±Ÿè‹æ©åŽè¯ä¸šå…¬å¸ï¼Œäº§å“批å·ï¼š20080303)20 ml+生ç†ç›æ°´10 ml。两组患者术å‰ç”¨è¯å‡ä¸ºåœ°è¥¿æ³®10 mg,阿托å“0.5 mg。患者入室åŽï¼Œå¸¸è§„监测心率(HR)ã€è¡€åŽ‹(BP)ã€å¿ƒç”µå›¾(ECG)和动脉血氧饱和度(SpO2) ......
